NCT03956290

Brief Summary

The TREAT Pilot is a 3 months open-label pilot study to examine the effect of restricting the duration of eating (Time Restricted EATing) in metabolically unhealthy adults with overweight or obesity. This pilot study will allow the investigator to collect preliminary data for the design of a larger study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 11, 2021

Completed
Last Updated

July 19, 2021

Status Verified

July 1, 2021

Enrollment Period

1.5 years

First QC Date

May 16, 2019

Last Update Submit

July 13, 2021

Conditions

Keywords

Time restricted eatingOverweightObesityMetabolic syndromeDiabetes treated with metformin and/or diet and HbA1C< 7%Pre DiabetesCircadian rhythm

Outcome Measures

Primary Outcomes (2)

  • Percentage of participants logging

    To measure the usage of app by recording the total number of days the participants logged in during study. Reported in percentage from 0 to 100% of time in use.

    3 months

  • Percentage of patients who reduced eating duration by 4 hours

    Change in eating duration from pre- to post-intervention will be calculated in from data collected in hours spent eating

    3 months

Secondary Outcomes (5)

  • % weight loss achieved post-intervention

    Baseline to 3 months

  • Average time in duration of overnight fasting

    3 months

  • Average time in sleep duration

    3 months

  • Adherence to using the app

    3 months

  • % of participants who achieve ≥ 5% weight loss

    Baseline to 3 months

Study Arms (1)

TREAT pilot study

EXPERIMENTAL

Metabolically unhealthy overweight or obese potential participants who pass an in-person screen will enroll in a 2-week run-in period when they will use the app, to assess meal patterns under habitual living conditions.

Behavioral: TREAT pilot intervention

Interventions

Participants will be asked to use the app and take pictures of everything they eat and drink, from the time they get up to the time they go to bed, regardless of size of meal/snacks/drink, for 2 weeks. This will generate data on their eating pattern and eating duration. Participants will be reminded through app, call or text by study staff based on personalized eating schedule. The sleep schedule will also be recorded.

Also known as: TREAT
TREAT pilot study

Eligibility Criteria

Age45 Years - 73 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age: 45-73y old
  • overweight or obesity with BMI ≥25.0 and ≤35.0 kg/m2
  • pre-diabetes or diabetes only diet controlled (HbA1c \<7%)
  • elevated Blood Pressure (BP) 120-129/\<80 mmHg or stage 1 high BP 130-139/80-89 mmHg, with clinical Atherosclerotic Cardiovascular Disease (ASCVD) or estimated 10-y Cardiovascular Disease (CVD) risk \<10%
  • having LDL cholesterol \<150mg/dl
  • no known sleep, psychiatric or food intake disorders
  • in possession of a smart phone
  • English-speaking
  • must live in New York city geographical area and not have planned travel schedule interfering with the study

You may not qualify if:

  • history or clinical evidence of condition that affect sleep
  • significant organ system dysfunction/disease: diabetes, severe pulmonary, kidney or cardiovascular disease, and any evidence of active illness (e.g., fever)
  • history of seizure disorder
  • being on medications for diabetes, hypertension or dyslipidemia
  • previous bariatric surgery
  • history or current significant psychiatric disorder
  • use dietary supplements and/or medications known to affect sleep, circadian rhythms or metabolic function
  • smoking tobacco or using illegal or recreational drugs
  • consume excessive alcohol (women: \>14 drinks/wk; men: \>21 drinks/wk)
  • consume large amounts of caffeine daily (\>2 cups of coffee or 8 oz caffeinated drinks per day)
  • participate in intense exercise (causing heavy breathing and sweating, such as jogging) \>2 d/wk for ≥35 min or moderate exercise (e.g., brisk walking) for \>150 min/wk
  • shift work
  • extreme early and late chronotypes
  • unwilling/unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Obesity Nutrition Research Center

New York, New York, 10032-3702, United States

Location

Related Publications (1)

  • Prasad M, Fine K, Gee A, Nair N, Popp CJ, Cheng B, Manoogian ENC, Panda S, Laferrere B. A Smartphone Intervention to Promote Time Restricted Eating Reduces Body Weight and Blood Pressure in Adults with Overweight and Obesity: A Pilot Study. Nutrients. 2021 Jun 23;13(7):2148. doi: 10.3390/nu13072148.

MeSH Terms

Conditions

OverweightObesityGlucose IntoleranceIntermittent FastingMetabolic Syndrome

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesFastingFeeding BehaviorBehaviorInsulin ResistanceHyperinsulinism

Study Officials

  • Blandine Laferrère, M.D., PhD.

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 20, 2019

Study Start

July 1, 2019

Primary Completion

January 11, 2021

Study Completion

January 11, 2021

Last Updated

July 19, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations